Literature DB >> 4317860

Pseudo-primary aldosteronism. An entity distinct from true primary aldosteronism.

L Baer, S C Sommers, L R Krakoff, M A Newton, J H Laragh.   

Abstract

Mesh:

Substances:

Year:  1970        PMID: 4317860

Source DB:  PubMed          Journal:  Circ Res        ISSN: 0009-7330            Impact factor:   17.367


× No keyword cloud information.
  9 in total

1.  Screening for adrenal forms of hypertension.

Authors:  L Baer
Journal:  Bull N Y Acad Med       Date:  1976 Jul-Aug

2.  Evaluation of renal vascular hypertension and primary hyperaldosteronism.

Authors: 
Journal:  Calif Med       Date:  1971-12

3.  The management of patients with primary aldosteronism.

Authors:  P O Granberg; U Adamson; K H Cohn; B Hamberger; P E Lins
Journal:  World J Surg       Date:  1982-11       Impact factor: 3.352

4.  Autoimmune mechanisms activating the angiotensin AT1 receptor in 'primary' aldosteronism.

Authors:  David C Kem; Hongliang Li; Carolina Velarde-Miranda; Campbell Liles; Megan Vanderlinde-Wood; Allison Galloway; Muneer Khan; Caitlin Zillner; Alexandria Benbrook; Veitla Rao; Celso E Gomez-Sanchez; Madeleine W Cunningham; Xichun Yu
Journal:  J Clin Endocrinol Metab       Date:  2014-02-19       Impact factor: 5.958

5.  Cellular and Genetic Causes of Idiopathic Hyperaldosteronism.

Authors:  Kei Omata; Fumitoshi Satoh; Ryo Morimoto; Sadayoshi Ito; Yuto Yamazaki; Yasuhiro Nakamura; Sharath K Anand; Zeng Guo; Michael Stowasser; Hironobu Sasano; Scott A Tomlins; William E Rainey
Journal:  Hypertension       Date:  2018-10       Impact factor: 10.190

6.  Comparison of surgery and prolonged spironolactone therapy in patients with hypertension, aldosterone excess, and low plasma renin.

Authors:  J J Brown; D L Davies; J B Ferriss; R Fraser; E Haywood; A F Lever; J I Robertson
Journal:  Br Med J       Date:  1972-06-24

7.  Aldosterone suppression with dopamine infusion in low-renin hypertension.

Authors:  O B Holland; C Thomas; H Brown; D Schindewolf; Y Hillier; C Gomez-Sanchez
Journal:  J Clin Invest       Date:  1983-09       Impact factor: 14.808

8.  Concurrent Primary Aldosteronism and Renal Artery Stenosis: An Overlooked Condition Inducing Resistant Hypertension.

Authors:  Lin Zhao; Jinhong Xue; Yi Zhou; Xueqi Dong; Fang Luo; Xiongjing Jiang; Xinping Du; Xianliang Zhou; Xu Meng
Journal:  Front Cardiovasc Med       Date:  2022-03-03

9.  Changes in the clinical manifestations of primary aldosteronism.

Authors:  Sun Hwa Kim; Jae Hee Ahn; Ho Cheol Hong; Hae Yoon Choi; Yoon Jung Kim; Nam Hoon Kim; Hye Jin Yoo; Hee Young Kim; Ji A Seo; Nan Hee Kim; Sin Gon Kim; Kyung Mook Choi; Sei Hyun Baik; Dong Seop Choi
Journal:  Korean J Intern Med       Date:  2014-02-27       Impact factor: 2.884

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.